Related news for:   cancer

February is Ovarian Cancer Awareness Month held to educate people however Mater is providing hope with research and treatment.

10

Feb

Ovarian Cancer Research at Mater

Mater Researcher A/Prof Kristen Radford has been awarded a 2020 Fulbright Future Scholarship allowing her to progress her cancer research with a four month sabbatical at the Tisch Cancer Institute.

03

Feb

Associate Professor Kristen Radford receives 2020 Fulbright scholarship

Professor Brian Gabrielli and team seek out the to answer a question—what is broken in melanomas that allows the damage to accumulate rather than repair, leading to mutations?

02

Dec

New light in melanoma research

Collaboration between clinical research institutes the Griffith Institute for Drug Discovery, Mater Research and Translational Research Institute has led to a breakthrough in cancer research.

25

Nov

Brisbane Based Breakthrough in Cancer Research

Mater Researcher Dr Felicity Davis has been awarded one of two $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia.

05

Nov

Dr Felicity Davis awarded Metcalf prize

Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.

04

Sep

Mater Research CEO appointed to new National Blood Cancer Taskforce

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.

29

Aug

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma

More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.

18

Jul

New score to help navigate improved treatment for follicular lymphoma patients

Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.

18

Feb

$3.6 million awarded to develop treatment for relapsed lymphoma patients

Dr Seth Cheetham has been awarded three grants to fund research projects addressing the role of genomic plasticity in cancer treatment.

12

Feb

Mater Researcher secures trio of funding for cancer research